Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
International Journal of Cancer
|
November 24, 2018
A controlled trial of HNSCC patient-derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growth
Kara M Ruicci, Jalna Meens, Ren X Sun, et al.
Molecular Oncology
|
December 6, 2019
Erratum to: Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition
Kara M Ruicci, Paul Plantinga, Nicole Pinto, et al.
Molecular Oncology
|
August 9, 2019
Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition
Kara M Ruicci, Paul Plantinga, Nicole Pinto, et al.
Plos One
|
December 31, 2019
Common trust and personal safety issues: A systematic review on the acceptability of health and social interventions for persons with lived experience of homelessness
Olivia Magwood, Vanessa Ymele Leki, Victoire Kpade, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 16, 2020
TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma
Kara M Ruicci, Jalna Meens, Paul Plantinga, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale
|
February 23, 2022
Introduction and expression of PIK3CA<sup>E545K</sup> in a papillary thyroid cancer BRAF<sup>V600E</sup> cell line leads to a dedifferentiated aggressive phenotype
Nicole Pinto, Kara M Ruicci, Mohammed Imran Khan, et al.
Pathology Oncology Research : POR
|
August 15, 2015
Feasibility of Targeting PIK3CA Mutations in Head and Neck Squamous Cell Carcinoma
Julie A Theurer, William Stecho, John Yoo, et al.
Plos One
|
November 13, 2018
Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models
Nicole Pinto, Stephenie D Prokopec, Frederick Vizeacoumar, et al.
Oncotarget
|
June 15, 2018
High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell lines
Farhad Ghasemi, Morgan Black, Ren X Sun, et al.
Plos One
|
September 24, 2020
Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer models
Nicole Pinto, Stephenie D Prokopec, Farhad Ghasemi, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
International Journal of Cancer
|
November 24, 2018
A controlled trial of HNSCC patient-derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growth
Kara M Ruicci, Jalna Meens, Ren X Sun, et al.
Molecular Oncology
|
December 6, 2019
Erratum to: Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition
Kara M Ruicci, Paul Plantinga, Nicole Pinto, et al.
Molecular Oncology
|
August 9, 2019
Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition
Kara M Ruicci, Paul Plantinga, Nicole Pinto, et al.
Plos One
|
December 31, 2019
Common trust and personal safety issues: A systematic review on the acceptability of health and social interventions for persons with lived experience of homelessness
Olivia Magwood, Vanessa Ymele Leki, Victoire Kpade, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 16, 2020
TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma
Kara M Ruicci, Jalna Meens, Paul Plantinga, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale
|
February 23, 2022
Introduction and expression of PIK3CA<sup>E545K</sup> in a papillary thyroid cancer BRAF<sup>V600E</sup> cell line leads to a dedifferentiated aggressive phenotype
Nicole Pinto, Kara M Ruicci, Mohammed Imran Khan, et al.
Pathology Oncology Research : POR
|
August 15, 2015
Feasibility of Targeting PIK3CA Mutations in Head and Neck Squamous Cell Carcinoma
Julie A Theurer, William Stecho, John Yoo, et al.
Plos One
|
November 13, 2018
Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models
Nicole Pinto, Stephenie D Prokopec, Frederick Vizeacoumar, et al.
Oncotarget
|
June 15, 2018
High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell lines
Farhad Ghasemi, Morgan Black, Ren X Sun, et al.
Plos One
|
September 24, 2020
Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer models
Nicole Pinto, Stephenie D Prokopec, Farhad Ghasemi, et al.
Page
of 5